Patient Education

Patient Education

Patient-focused tear sheets produced by ASH in collaboration with patient organizations

Understanding Mantle Cell Lymphoma

Lymphoma is the most common blood cancer. The two main forms of lymphoma are Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL). Mantle cell lymphoma...

Understanding von Willebrand Disease

Von Willebrand disease (vWD) is a genetic bleeding disorder caused by a deficient or defective von Willebrand factor (vWF). vWF is a clotting protein...

Understanding Childhood Cancer

Childhood cancers make up less than 1 percent of all cancers diagnosed each year. About 10,380 children in the United States under the age...

Sickle Cell Trait and Blood, Organ, and Tissue Donation

People with sickle cell trait can donate blood, organ, and tissues. Yet, fear and commonly held misperceptions keep them from donating to those whose...

What is Aplastic Anemia?

Aplastic anemia is a rare but serious disease of the bone marrow. Each year, between 600 and 900 people in the United States are...

Get Screened to Know Your Sickle Cell Status

To find out whether you or your loved one has sickle cell disease (SCD) or sickle cell trait (SCT), blood tests must be done to screen...

How Does Cancer Develop?

Nearly one out of every two Americans will be diagnosed with cancer in his or her lifetime, and worldwide, cancer incidence is predicted to...

Understanding Hemophilia

A bleeding disorder is a condition in which a person tends to bleed longer (not faster) before a blood clot forms to stop the bleeding....

What is Multiple Myeloma?

Multiple myeloma, also known as myeloma, is the second most common blood cancer in the United States. There has been great progress in the development...

What You Should Know About Sickle Cell Trait

Sickle cell trait (SCT) is not a mild form of sickle cell disease. Having SCT simply means that a person carries a single gene for sickle...
Advertisement

Current Issue

October 2019, Volume 5, Issue 12

This issue highlights the unintended consequences of fighting the nation’s opioid epidemic, considers the optimal frontline regimen for myeloma, and more.